Our Team

Our Team

A world-class team dedicated to transforming the treatment of cancer

We have assembled the best and brightest team of scientists and industry professionals with a strong passion for science and collaboration. Our leadership team, our world-class scientific advisors, and our engaged directors are working together to advance our next-generation immunotherapies and to give patients hope in their fight against cancer.

Management

 

Daniel Lynch

Daniel Lynch

Executive Chairman, Interim CEO
Jeff Goater

Jeff Goater

Chief Business Officer
Scott Chappel, PhD

Scott Chappel, PhD

Chief Technology Officer
Jessica Fees

Jessica Fees

Head of Finance
Nicholas Buffinger, PhD, JD

Nicholas Buffinger, PhD, JD

Head of Corporate Development and IP Strategy
Pamela Holland, PhD

Pamela Holland, PhD

Vice President, Cancer Biology
Lisa McGrath,

Lisa McGrath,

Vice President, Human Resources
Vito Palombella, PhD

Vito Palombella, PhD

Chief Scientific Officer
Robert Ross, MD

Robert Ross, MD

Chief Medical Officer

Board of Directors

Scientific Advisory Board